Skip to main content
×
×
Home

Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis

  • Antti Mustonen (a1), Solja Niemelä (a2), Tanja Nordström (a1), Graham K. Murray (a3), Pirjo Mäki (a4), Erika Jääskeläinen (a5) and Jouko Miettunen (a5)...
Abstract
Background

The association between cannabis use and the risk of psychosis has been studied extensively but the temporal order still remains controversial.

Aims

To examine the association between cannabis use in adolescence and the risk of psychosis after adjustment for prodromal symptoms and other potential confounders.

Method

The sample (n = 6534) was composed of the prospective general population-based Northern Finland Birth Cohort of 1986. Information on prodromal symptoms of psychosis and cannabis use was collected using questionnaires at age 15–16 years. Participants were followed up for ICD-10 psychotic disorders until age 30 years using nationwide registers.

Results

The risk of psychosis was elevated in individuals who had tried cannabis five times or more (hazard ratio, (HR) = 6.5, 95% CI 3.0–13.9). The association remained statistically significant even when adjusted for prodromal symptoms, other substance use and parental psychosis (HR = 3.0, 95% CI 1.1–8.0).

Conclusions

Adolescent cannabis use is associated with increased risk of psychosis even after adjustment for baseline prodromal symptoms, parental psychosis and other substance use.

Declaration of interest

None.

Copyright
Corresponding author
Correspondence: Antti Mustonen, Center for Life Course Health Research, University of Oulu, P.O. Box 5000, 90014 University of Oulu, Finland. Email: antti.mustonen@student.oulu.fi
References
Hide All
1Marconi, A, Di Forti, M, Lewis, CM, Murray, RM, Vassos, E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull 2016; 42: 1262–9.
2Henquet, C, Murray, R, Linszen, D, van Os, J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31: 608–12.
3Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 28: 319–28.
4Semple, DM, McIntosh, AM, Lawrie, SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005; 19: 187–94.
5Large, M, Sharma, S, Compton, MT, Slade, T, Nielssen, O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 2011; 68: 555–61.
6Myles, N, Newall, H, Nielssen, O, Large, M. The association between cannabis use and earlier age at onset (1) of schizophrenia and other psychoses: meta-analysis of possible confounding factors. Curr Pharm Des 2012; 18: 5055–69.
7Gage, SH, Hickman, M, Zammit, S. Association between cannabis and psychosis: epidemiologic evidence. Biol Psychiatry 2016; 79: 549–56.
8Arseneault, L, Cannon, M, Poulton, R, Murray, R, Caspi, A, Moffitt, TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212–3.
9Henquet, C, Krabbendam, L, Spauwen, J, Kaplan, C, Lieb, R, Wittchen, HU, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330: 11.
10Kelley, ME, Wan, CR, Broussard, B, Crisafio, A, Cristofaro, S, Johnson, S, et al. Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders. Schizophr Res 2016; 17: 62–7.
11Bechtold, J, Hipwell, A, Lewis, DA, Loeber, R, Pardini, D. Concurrent and sustained cumulative effects of adolescent marijuana use on subclinical psychotic symptoms. Am J Psychiatry 2016; 173: 781–9.
12Auther, AM, Cadenhead, KS, Carrion, RE, Addington, J, Bearden, CE, Cannon, TD, et al. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatr Scand 2015; 132: 60–8.
13Miettunen, J, Tormanen, S, Murray, GK, Jones, PB, Maki, P, Ebeling, H, et al. Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry 2008; 192: 470–1.
14Jarvelin, MR, Hartikainen-Sorri, AL, Rantakallio, P. Labour induction policy in hospitals of different levels of specialisation. Br J Obstet Gynaecol 1993; 100: 310–5.
15Heinimaa, M, Salokangas, RK, Ristkari, T, Plathin, M, Huttunen, J, Ilonen, T, et al. PROD-screen--a screen for prodromal symptoms of psychosis. Int J Methods Psychiatr Res 2003; 12: 92104.
16Filatova, S, Marttila, R, Koivumaa-Honkanen, H, Nordstrom, T, Veijola, J, Maki, P, et al. A comparison of the cumulative incidence and early risk factors for psychotic disorder in young adults in the Northern Finland Birth Cohorts 1966 and 1986. Epidemiol Psychiatr Sci 2016; 28: 111.
17Power, RA, Verweij, KJ, Zuhair, M, Montgomery, GW, Henders, AK, Heath, AC, et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry 2014; 19: 1201–4.
18Nesvag, R, Reichborn-Kjennerud, T, Gillespie, NA, Knudsen, GP, Bramness, JG, Kendler, KS, et al. Genetic and environmental contributions to the association between cannabis use and psychotic-like experiences in young adult twins. Schizophr Bull 2017; 43: 644653.
19Yung, AR, Nelson, B, Baker, K, Buckby, JA, Baksheev, G, Cosgrave, EM. Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust N Z J Psychiatry 2009; 43: 118–28.
20Granö, N, Karjalainen, M, Itkonen, A, Anto, J, Edlund, V, Heinimaa, M, et al. Differential results between self-report and interview-based ratings of risk symptoms of psychosis. Early Interv Psychiatry 2011; 5: 309–14.
21Horwood, J, Salvi, G, Thomas, K, Duffy, L, Gunnell, D, Hollis, C, et al. IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br J Psychiatry 2008; 193: 185–91.
22Bagot, KS, Milin, R, Kaminer, Y. Adolescent initiation of cannabis use and early-onset psychosis. Subst Abus 2015; 36: 524533.
23Radhakrishnan, R, Wilkinson, ST, D'Souza, DC. Gone to pot - a review of the association between cannabis and psychosis. Front Psychiatry 2014; 5: 54.
24Sherva, R, Wang, Q, Kranzler, H, Zhao, H, Koesterer, R, Herman, A, et al. Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks. JAMA Psychiatry 2016; 73: 472–80.
25Gage, SH, Hickman, M, Heron, J, Munafo, MR, Lewis, G, Macleod, J, et al. Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children. Psychol Med 2014; 44: 3435–44.
26Thanki, D, Matias, J, Griffiths, P, Noor, A, Olszewski, D, Simon, R, et al. Prevalence of Daily Cannabis Use in the European Union and Norway. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2012.
27Di Forti, M, Sallis, H, Allegri, F, Trotta, A, Ferraro, L, Stilo, SA, et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull 2014; 40: 1509–17.
28Murray, RM, Quigley, H, Quattrrone, D, Englund, A, Di Forti, M. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry 2016; 15: 195204.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis

  • Antti Mustonen (a1), Solja Niemelä (a2), Tanja Nordström (a1), Graham K. Murray (a3), Pirjo Mäki (a4), Erika Jääskeläinen (a5) and Jouko Miettunen (a5)...
Submit a response

eLetters

Letter to editor

navya saluja, Junior Resident, Pt. B.D. Sharma PGIMS Rohtak
Hitesh Khurana, Senior Professor, Pt. B.D. Sharma PGIMS Rohtak
15 May 2018

Dear Editor

I read the article by Antti Mustonen et al(1) entitled "Adolecent cannabis use, baseline prodromal symptoms and the risk of psychosis" has been a tremendous study and is well conceptualised.with great interest. I would like to make certain comments.

In the section of Methods with the subheading of psychosis diagnosis - the ICD diagnosis have have been mentioned as (F22-29,F302, F312 ...) wheres The fourth character in ICD-10 codes is always a ‘dot’ Secondly the codes F302 and F312 are also mentioned under the category of psychoasis. If these codes refer to F30.2 and F31.2 respectively then these fall in the category of affective disorder without psychosis. These errors in reporting make the article quite difficult to follow.

There is also a mismatch between the figures and the text of article. In the results Figure 2 explaining the cumulative incidences of psychosis in four groups with and without cannabis use and prodromal symptoms in the Northern Finland Cohort 1986 is not self explanatory as the figures (n=13/134, 5/134...) has not been explained in the text and I found difficult to understand the origin and meaning of these figures.

Similarly, while mentioning about association between adolesecent cannabis use and subsequent psychosis (page 230 first paragraph of associations between adolescent cannabis use and subsequent

psychosis) the authors have mentioned that 18 out of 375 (4.8%) cannabis users received a diagnosis of psychosis during the 15-year follow-up (4 narrow-defined schizophrenia, 4 schizophrenia spectrum disorder, 0 bipolar disorder with psychotic features, 7 major depression with psychotic features, 3 other psychosis). As 7 out of 18 participants had major depression with psychotic features which is a mood disorder and inclusion of it in the criteria would lead to inaccurate results. If excluding the 7 participants, there would be 11 participants who had psychosis. The participants should have been more for better explanation of the hypothesis formulated for the study.

It would be of great help if the authors could clarify these points.

Thank you

References

1. Mustonen A, Niemelä S, Nordström T, Murray GK, Mäki P, Jääskeläinen E. Adolescent cannabis use , baseline prodromal symptoms and the risk of psychosis. Br J Psychiatry. 2018;212(4):227–33.

2. ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Disgnostic Guidelines. Geneva. World Health Organisation. 1992.

... More

Conflict of interest: None declared

Write a reply

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *